GFAP and Alzheimer disease: The stimulus capable of inducing astrocyte reactivity in AD brains is still under debate; however, studies using aggregated Aβ protein and the intact core of Aβ plaques isolated from AD brain tissue have shown that Aβ can trigger activation of astrocytes in vitro, causing GFAP up-regulation and morphological changes (DeWitt et al., 1998).